Showing results (31-40 of 345) with videos related to
Sort By:
Pageof 35
Brain Sciences|June 2, 2021
A Randomized Computer-Assisted Rehabilitation Trial of Attention in Pediatric Multiple Sclerosis: A Post Hoc AnalysisMarta Simone, Rosa Gemma Viterbo, Lucia Margari, et al.European Neurology|November 17, 2015
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational StudyMaria Trojano, Carlos VilaEuropean Neurology|October 13, 2016
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily PracticePatrick Vermersch, Maria TrojanoDrugs - Real World Outcomes|March 14, 2025
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World CohortTommaso Guerra, Francesca Caputo, Antonella Bianco, et al.Medicina (Kaunas, Lithuania)|December 31, 2025
Assessment of the RoAD Score as a Predictor of Long-Term Irreversible Ambulatory Disability in Multiple Sclerosis: Evidence from a Real-World CohortTommaso Guerra, Chiara Esposto, Sara Limitone, et al.Clinical Neurology and Neurosurgery|August 19, 2024
Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case seriesAntonella Bianco, Tommaso Guerra, Francesca Caputo, et al.Journal of Neurology|March 27, 2024
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS scoreGiulia Mallucci, Ottavia Eleonora Ferraro, Maria Trojano, et al.Nature Reviews. Neurology|April 3, 2019
Author Correction: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia AmatoTherapeutic Advances in Neurological Disorders|April 9, 2019
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysisLuca Prosperini, Revere P Kinkel, Augusto A Miravalle, et al.Journal of Neuroimmunology|September 3, 2004
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsMaurizio Giorelli, Paolo Livrea, Maria TrojanoPageof 35